FDA approves first diagnostic tool to target triple-negative breast cancer patients
March 11, 2019Sales and Marketing Cancer, Roche, Ventana, breast cancer, pharma
Roche’s Ventana PD-L1 Assay has become the first FDA-approved companion diagnostic for the identification of patients with triple-negative breast cancer …
AMAG Pharmaceuticals’ shares fall 21% after failed Makena trial
March 11, 2019Sales and Marketing AMAG Pharmaceuticals, Makena, PROLONG, birth, trials
AMAG Pharmaceuticals’ Makena (hydroxyprogesterone caproate) has failed to meet its co-primary endpoints in a trial of patients with a history …
FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults
March 11, 2019Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma
Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …
US DoJ launch investigation into Acadia Pharmaceuticals
March 11, 2019Sales and Marketing False Claims Act, SEC, acadia, antipsychotics, kickbacks
The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …
23andMe to offer genetic reports on diabetes
March 11, 2019Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics
Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …
FDA Commissioner Scott Gottlieb announces resignation
March 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
Measles cases in Greater Manchester surge to 32 since January, lack of vaccination blamed
March 8, 2019Medical Communications Europe, MMR, UK, WHO, measles, pharma, vaccines
There has been a sharp increase in cases of measles across Greater Manchester, Public Health England has warned, following increasingly …
Top Ten most popular articles on Pharmafile.com this week!
March 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Gilead, HIV, Novartis, Scott Gottlieb, top 10
HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …
Monthly injections offer similar efficacy to daily pills in HIV phase 3 trials
March 8, 2019Medical Communications ATLAS, GSK, HIV, ViiV, flair, injectable
A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare and J&J subsidiary Jannsen, …
Roche’s Tecentriq combo scoops up European approval in first-line metastatic lung cancer
March 8, 2019Medical Communications, Sales and Marketing Cancer, Europe, European Commission, NSCLC, Roche, lung cancer, pharma
Roche has announced the approval of the European Commission for its PD-L1 inhibitor Tecentriq (atezolizumab) when used in combination with …
Dutch pharmacists to circumvent Novartis cancer drug market exclusivity
March 8, 2019Medical Communications Bruno Bairns, Cancer, Luathera, Novartis, aaa
Dutch pharmacists have vowed to circumvent rules enforcing Novartis’ market exclusivity for radioactive cancer drug Lutathera. Pharmacists at Erasmus, …
Glenmark spinoff name Gilead VP Alessandro Riva as new CEO
March 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Gilead’s Dr Alessandro Riva, is stepping down from his position as the company’s Executive Vice President, Oncology Therapeutics to head …
Gilead’s Biktarvy maintains HIV suppression for 48 weeks in children and adolescents
March 7, 2019Research and Development Biktarvy, Gilead, HIV, pharma
Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 …
Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea
March 7, 2019Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries
A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …
Allergan’s depression drug rapastinel fails to outperform placebo at Phase 3
March 7, 2019Research and Development Allergan, FDA, depression, major depressive disorder, pharma, rapastinel
As Janssen celebrated the FDA approval of the first novel therapy for depression in three decades with Spravato, Allergan released …
Public satisfaction with NHS falls to lowest point since 2007
March 7, 2019Medical Communications England, King's, NHS, Nuffield, Scotland, UK, Wales, kings, public stisfaction
Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social …
Médecins Sans Frontières (MSF)/ Doctors Without Borders calls on CEPI to revise ‘toothless’ access policy
March 6, 2019Sales and Marketing CEPI, MSF, access, public health, tokyo, vaccines
The humanitarian organisation Médecins Sans Frontières (MSF) has called on The Coalition for Epidemic Preparedness Innovations (CEPI) to revise their …
FDA Commissioner Scott Gottlieb announces resignation
March 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
Indian measles vaccination campaign saved tens of thousands of lives
March 6, 2019Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines
A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …
Janssen’s party drug-based nasal spray becomes first new FDA-approved depression treatment in 30 years
March 6, 2019Research and Development, Sales and Marketing Janssen, Spravato, depression, esketamine, pharma
The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
